Sprycel Market with COVID-19 Impact Analysis, By Demographic (Age, Gender, Income), By Psychographic (Lifestyle, Attitudes), By Behavioral (Usage Rate, Compliance, Treatment History), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Sprycel Market size was valued at USD 5,470 Million in 2022, expanding at a CAGR of 5.2% from 2023 to 2030.
Sprycel (dasatinib) is a prescription drug used to treat some kinds of leukemia as well as other blood diseases. It belongs to the tyrosine kinase inhibitor family of medicines. Sprycel works by inhibiting the function of particular proteins involved in cancer cell proliferation and spread. This drug is used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). It is normally administered orally and plays an important role in treating certain hematologic malignancies, improving patient outcomes, and slowing disease progression.
Sprycel Market- Market Dynamics
- Its efficacy in targeting specific cancer-related proteins, known as tyrosine kinases propel market demand
Precision medicine, which tailor’s therapies based on a patient\'s genetic and molecular profile, has resulted in targeted therapy. Dasatinib, which is being developed as a therapy for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), is an example of this technique. Sprycel interrupts the signaling pathways that drive cancer cell development by reducing the activity of tyrosine kinases, providing a more effective and less toxic alternative to standard chemotherapy and thereby improving the prognosis for patients with these illnesses.
Sprycel Market- Key Insights
- As per the analysis shared by our research analyst, the global Sprycel market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2023-2030)
- The Sprycel industry is projected to grow at a significant rate due to Its efficacy in targeting specific cancer-related proteins, known as tyrosine kinases.
- Based on Demographic segmentation, Age was predicted to show maximum market share in the year 2022
- Based on Psychographic segmentation, Lifestyle was the leading Demographic in 2022
- On the basis of region, Asia Pacific was the leading revenue generator in 2022
Sprycel Market- Segmentation Analysis:
The Global Sprycel Market is segmented on the basis of Demographic, Psychographic, Behavioral, and Region.
The market is divided into four categories based on Demographic: Age, Gender, Income. The Age segment dominates the market. Sprycel (dasatinib) demand is largely driven by its usage in treating particular types of leukaemia that are more common in older persons. Chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) are becoming increasingly frequent in the elderly population, increasing need for targeted medicines such as Sprycel.
The market is divided into two categories based on Psychographic: Lifestyle, Attitudes. The Lifestyle sector dominates the market and is likely to maintain its dominance during the forecast period. Sprycel (dasatinib) lifestyle demand generally consists of people modifying their habits to accommodate therapy. To manage possible side effects, patients may need to stick to a regular prescription regimen and adopt dietary and exercise changes. While receiving Sprycel medication, lifestyle decisions that promote general well-being are often prioritized.
Sprycel Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Sprycel (dasatinib) demand in the Asia-Pacific area has been continuously growing due to a variety of variables. Owing to population expansion and aging, the area has seen an increase in the frequency of hematological malignancies such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Second, advances in healthcare infrastructure, diagnostics, and the availability of innovative therapeutics have increased awareness of and demand for sophisticated treatments. Third, the Asia-Pacific region\'s expanding pharmaceutical sector and research partnerships are making targeted medicines like Sprycel more accessible. These factors contribute to the region\'s strong demand for Sprycel, giving patients fighting these life-threatening illnesses hope.
Sprycel Market- Competitive Landscape:
Several main companies dominate the competitive landscape of tyrosine kinase inhibitors for hematological malignancies, including Sprycel (dasatinib). Sprycel\'s maker, Bristol Myers Squibb, has a substantial market share. However, competition comes from other pharmaceutical firms that manufacture comparable medications, such as imatinib and nilotinib. Competition is aided by ongoing research efforts to create more effective and focused medicines in this class. Furthermore, generic versions of these drugs have an impact on the landscape by offering patients with more cost choices. The competitive environment encourages innovation and guarantees that patients with leukaemia and associated illnesses have access to a variety of treatment alternatives.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SPRYCEL MARKET KEY PLAYERS
- Bristol-Myers Squibb (BMS)
- Novartis
- Teva Pharmaceutical Industries
- Mylan
- Accord Healthcare
- Sun Pharma
- Dr Reddy\'s Laboratories
- Aurobindo Pharma
- LUCIUS Pharma
GLOBAL SPRYCEL MARKET, BY DEMOGRAPHIC
- Age
- Gender
- Income
GLOBAL SPRYCEL MARKET, BY PSYCHOGRAPHIC
- Lifestyle
- Attitudes
GLOBAL SPRYCEL MARKET, BY BEHAVIORAL
- Usage Rate
- Compliance
- Treatment History
GLOBAL SPRYCEL MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Sprycel Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Sprycel Market Snippet by Demographic
2.1.2. Sprycel Market Snippet by Psychographic
2.1.3. Sprycel Market Snippet by Behavioral
2.1.4. Sprycel Market Snippet by Country
2.1.5. Sprycel Market Snippet by Region
2.2. Competitive Insights
3. Sprycel Key Market Trends
3.1. Sprycel Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Sprycel Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Sprycel Market Opportunities
3.4. Sprycel Market Future Trends
4. Sprycel Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Sprycel Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Sprycel Market Landscape
6.1. Sprycel Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Sprycel Market – By Demographic
7.1. Overview
7.1.1. Segment Share Analysis, By Demographic, 2022 & 2030 (%)
7.1.2. Age
7.1.3. Gender
7.1.4. Income
8. Sprycel Market – By Psychographic
8.1. Overview
8.1.1. Segment Share Analysis, By Psychographic, 2022 & 2030 (%)
8.1.2. Lifestyle
8.1.3. Attitudes
9. Sprycel Market – By Behavioral
9.1. Overview
9.1.1. Segment Share Analysis, By Behavioral, 2022 & 2030 (%)
9.1.2. Usage Rate
9.1.3. Compliance
9.1.4. Treatment History
10. Sprycel Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Sprycel Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Sprycel Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Sprycel Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Sprycel Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Sprycel Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Sprycel Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Bristol-Myers Squibb (BMS)
11.2.2. Novartis
11.2.3. Teva Pharmaceutical Industries
11.2.4. Mylan
11.2.5. Accord Healthcare
11.2.6. Sun Pharma
11.2.7. Dr Reddy\'s Laboratories
11.2.8. Aurobindo Pharma
11.2.9. LUCIUS Pharma
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
